Breast massage to reduce side effects in breast cancer patients after surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates the effectiveness of manual lymphatic drainage breast massage in women undergoing radiation therapy after breast conserving surgery for localized breast cancer. The primary goal is to assess the feasibility of this massage technique in reducing treatment-related side effects such as lymphedema, pain, and impaired quality of life. Participants will receive the massage twice a week during radiation therapy and for one month afterward, with follow-up assessments at various intervals to evaluate outcomes. The study aims to provide insights into the tolerability and potential benefits of this intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Female with native breasts and localized breast cancer who are status post-lumpectomy surgery, will receive whole breast radiation therapy with/without nodal irradiation, with standard fractionation or moderate hypofractionation
* Age \>= 18 years
* Ability to understand and the willingness to sign a written informed consent in English or Spanish

Exclusion Criteria:

* Underlying diagnosis of chronic inflammatory illness or collagen vascular disorder, e.g. scleroderma, lupus, rheumatoid arthritis, fibromyalgia as these conditions may significantly affect the likelihood and magnitude of radiation related toxicity
* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, unstable cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
* Inability to provide written informed consent in English or Spanish
* Patients receiving ultra-hypofractionation, and/or partial breast or chest wall radiation therapy are excluded

Where it's running

• USC / Norris Comprehensive Cancer Center
  Los Angeles, California, United States Recruiting

Study contacts

• Principal investigator: May L Tao, MD — University of Southern California
• Study coordinator: Kimberly Arieli, RN
• Email: Kimberly.Arieli@med.usc.edu
• Phone: 323-865-0451

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Navigation program to boost survivorship support participation for non-metastatic breast cancer survivors

  This program tests whether a patient navigation service helps non-metastatic breast cancer survivors use survivorship support services more often.

  Recruiting Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT07699991

• Resistant potato starch to reduce joint and muscle symptoms in people starting aromatase inhibitors for early-stage or high-risk breast cancer

  This phase II trial will test whether taking resistant potato starch can reduce joint pain and stiffness in people with stage 0–III or high-risk breast cancer who are starting aromatase inhibitor therapy.

  Recruiting Phase 2 University of Michigan Rogel Cancer Center · Ann Arbor, Michigan · NCT07443943

• 5-strain probiotic to prevent bone loss during aromatase inhibitor therapy

  This trial will try a 5-strain probiotic called WBF-038 to see if it prevents bone loss in people with early-stage hormone receptor–positive breast cancer who are starting aromatase inhibitor therapy.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT07044310

• Improving skin quality and self-esteem in breast cancer survivors on hormone therapy

  This study is testing how hormone therapy affects skin quality and self-esteem in breast cancer survivors, while also offering skincare advice to see if it helps them feel better about themselves.

  Recruiting Mayo Clinic · Jacksonville, Florida · NCT06401889

• Personalized tumor vaccine with checkpoint inhibitors for triple negative breast cancer

  This phase I trial will test whether a personalized tumor membrane vesicle (TMV) vaccine, given alone or with pembrolizumab or ipilimumab, can boost immune response and help control disease in adults with triple negative breast cancer.

  Recruiting at 4 sites Phase 1 Emory University · Atlanta, Georgia and 3 other locations · NCT06324240

• Restoring nipple sensation after breast cancer surgery

  This study is testing if adding a special technique to nipple-sparing surgery can help women with breast cancer regain feeling in their nipples and improve their quality of life.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT06153836

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.